U.S. Genomics Announces New Chief Executive Officer
News Dec 16, 2005
U.S. Genomics has announced that John J. Canepa has been promoted to President, Chief Executive Officer and member of the Board of Directors.
"John's business acumen, combined with his extensive experience in the life sciences, represents an unparalleled set of qualifications to lead this company through its commercialization efforts and the next phase of its biodefense contract," said Gus Lawlor, Managing Director at HealthCare Ventures and a U.S. Genomics board member.
"We are excited to move forward in this next phase of biodefense development and commercialization of the single molecule biology technology under John's leadership."
Canepa originally joined U.S. Genomics as Chief Financial Officer. During his tenure as CFO, Canepa saw the Company through the development and launch of the Trilogy® 2020 platform and Direct™ miRNA assays and through two phases of a multi-million-dollar biodefense contract with the U.S. Department of Homeland Security.
Prior to joining U.S. Genomics, Canepa served as Vice President, Finance & Administration, and Chief Financial Officer of Winphoria Networks, Inc., a venture capital-backed telecommunications company.
Previously he was a senior partner in the Boston office of Arthur Andersen, where he led the firm's worldwide life sciences practice.
"U.S. Genomics has made great strides with its biodefense work and this is an especially exciting time to be part of this company," said Canepa.
"It is a privilege to lead such a dynamic team in both the biodefense applications and the development of the Trilogy 2020 platform and assays."
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE
Hidden Signals in RNAs Regulate Protein SynthesisNews
Scientists have long known that RNA encodes instructions to make proteins. In a new study published in Nature, scientists describe how the protein-making machinery identifies alternative initiation sites from which to start protein synthesis.READ MORE
ExPecto Patronum! Magical Machine Learning Tool Summons DNA Dark Matter DataNews
A new machine learning framework, dubbed ExPecto, can predict the effects of mutations in the so-called “dark matter” regions of the human genome. ExPecto pinpoints how mutations can disrupt the way genes turn on and off throughout your body.